Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Classificação em ações #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Preço da ação
$0.2219522
Última sincronização: 2025-09-11
Valor de mercado
$1.10B
Variação (1 dia)
0.04%
Variação (1 ano)
0.17%
País
CN
Negociar Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Lucros da Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Lucros em Sep 2024 TTM: $-246.31M
De acordo com os últimos relatórios financeiros da Hubei Biocause Pharmaceutical Co., Ltd., os ganhos atuais da empresa são de $-246.31M. Em 2022, a empresa teve ganhos de $32.59M, uma diminuição em relação a aos ganhos de 2021, que foram de $53.98M. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Hubei Biocause Pharmaceutical Co., Ltd. de 2000 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
2026 (TTM) $-246.31M -6.66%
2023 $-263.90M -909.84%
2022 $32.59M -39.64%
2021 $53.98M -75.67%
2020 $221.88M -57.48%
2019 $521.80M 36.14%
2018 $383.27M -8.47%
2017 $418.73M -15.31%
2016 $494.40M 859.98%
2015 $51.50M 192.79%
2014 $17.59M -182.99%
2013 $-21.20M -981.31%
2012 $2.40M -112.99%
2011 $-18.51M -493.30%
2010 $4.71M -45.74%
2009 $8.67M 709.23%
2008 $1.07M -93.04%
2007 $15.40M 107.42%
2006 $7.42M 610.69%
2005 $1.04M 72.62%
2004 $605.05K -110.58%
2003 $-5.72M -392.76%
2002 $1.95M -72.00%
2001 $6.97M 18.03%
2000 $5.91M 0.00%
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
$43.81B -17,885.82%
CN
$9.54B -3,973.90%
HK
- -
CA
- -
TW
- -
US